Similar articles

• Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery.

  Lette J, Waters D, Lapointe J, Gagnon A, Picard M, Cerino M, Kerouac M. Lette J, et al. Am J Cardiol. 1989 Aug 1;64(5):276-81. doi: 10.1016/0002-9149(89)90519-5. Am J Cardiol. 1989. PMID: 2756871
• Failure of negative dipyridamole thallium scans to predict perioperative myocardial ischaemia and infarction.

  Fleisher LA, Nelson AH, Rosenbaum SH. Fleisher LA, et al. Can J Anaesth. 1992 Feb;39(2):179-83. doi: 10.1007/BF03008653. Can J Anaesth. 1992. PMID: 1544202
• Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans?

  Massie MT, Rohrer MJ, Leppo JA, Cutler BS. Massie MT, et al. J Vasc Surg. 1997 Jun;25(6):975-82; discussion 982-3. doi: 10.1016/s0741-5214(97)70120-4. J Vasc Surg. 1997. PMID: 9201157
• Preoperative cardiac evaluation for vascular surgery.

  Chitilian HV, Isselbacher EM, Fitzsimons MG. Chitilian HV, et al. Int Anesthesiol Clin. 2005 Winter;43(1):1-14. doi: 10.1097/01.aia.0000148884.78733.22. Int Anesthesiol Clin. 2005. PMID: 15632514 Review. No abstract available.
• Prognostic impact of stress testing in coronary artery disease.

  Severi S, Michelassi C. Severi S, et al. Circulation. 1991 May;83(5 Suppl):III82-8. Circulation. 1991. PMID: 2022053 Review.